MedX Health Corp (MDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K ≈ $-497.43K USD) by net assets (CA$-10.02 Million ≈ $-7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MedX Health Corp (MDX) defensive interval to measure how many days the company can operate on defensive assets alone.
MedX Health Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MedX Health Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Just Group plc
LSE:JUST
|
0.765x |
|
TS Corp Preference Shares
KO:001795
|
0.047x |
|
Armlogi Holding Corp. Common Stock
NASDAQ:BTOC
|
-0.157x |
|
New Era Helium Inc Common Stock
NASDAQ:NEHC
|
0.362x |
|
Electric Royalties Ltd
V:ELEC
|
-0.027x |
|
Tae Won Mulsan
KO:001420
|
-0.030x |
|
Biofrontera Inc
NASDAQ:BFRI
|
-0.227x |
|
The Grob Tea Company Limited
NSE:GROBTEA
|
-0.064x |
Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of MedX Health Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-8.52 Million ≈ $-6.17 Million |
CA$-2.51 Million ≈ $-1.82 Million |
0.295x | -38.53% |
| 2023-12-31 | CA$-7.14 Million ≈ $-5.17 Million |
CA$-3.42 Million ≈ $-2.48 Million |
0.479x | +21.14% |
| 2022-12-31 | CA$-7.08 Million ≈ $-5.12 Million |
CA$-2.80 Million ≈ $-2.03 Million |
0.396x | -68.21% |
| 2021-12-31 | CA$-3.63 Million ≈ $-2.63 Million |
CA$-4.52 Million ≈ $-3.27 Million |
1.244x | -11.46% |
| 2020-12-31 | CA$-2.07 Million ≈ $-1.50 Million |
CA$-2.91 Million ≈ $-2.10 Million |
1.405x | +204.09% |
| 2019-12-31 | CA$-2.87 Million ≈ $-2.07 Million |
CA$-1.32 Million ≈ $-958.33K |
0.462x | -72.62% |
| 2018-12-31 | CA$-1.54 Million ≈ $-1.12 Million |
CA$-2.61 Million ≈ $-1.89 Million |
1.688x | +72.37% |
| 2017-12-31 | CA$-1.50 Million ≈ $-1.09 Million |
CA$-1.47 Million ≈ $-1.06 Million |
0.979x | +34.25% |
| 2016-12-31 | CA$-1.83 Million ≈ $-1.32 Million |
CA$-1.33 Million ≈ $-963.12K |
0.729x | +225.13% |
| 2015-12-31 | CA$-2.39 Million ≈ $-1.73 Million |
CA$-536.53K ≈ $-388.12K |
0.224x | -41.31% |
| 2014-12-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-864.08K ≈ $-625.06K |
0.382x | +814.58% |
| 2013-12-31 | CA$-3.40 Million ≈ $-2.46 Million |
CA$-141.94K ≈ $-102.68K |
0.042x | -- |
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more